TradesZ
Top 10 stocks to add now
← All picks
Premium · archive Published July 6, 2026
Momentus Inc. Class A Common Stock logo

Ticker

MNTS

Momentus Inc. Class A Common Stock

MNTS is still a space-race story, but cash and dilution matter

The thesis

Momentus has a real 2026 growth story now: Q1 service revenue jumped to $3.2 million from $0.3 million a year earlier, and management is guiding to about $10 million for full-year 2026.[2][3] The company says Vigoride 7 flew on SpaceX Transporter-16 with 10 payloads, and its Vigoride 8 mission is already fully booked for 2027, with NASA’s Juno RDRE and Spaceworks’ COSMIC payloads cleared through Preliminary Design Review under two NASA contracts.[2][3] Momentus also says it secured a new commercial contract for Vigoride-9 on June 17, 2026, which suggests the order book is still building.[9] The bull case is simple: if launches keep turning into paid missions, revenue can keep climbing faster than the company’s small starting base.[2][3]

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

💡 Why this matters

Retail investors care because Momentus sits in the kind of space theme that can move fast when there is real mission news, not just hype. This is a company tied to satellites, launch rides, and in-orbit services — basically the “tow truck and delivery van” layer of space.[7] When customers like SpaceX, NASA-linked programs, and other commercial payload owners show up, it can validate that the business is moving from concept to actual paid work.[2][3][9]

Catalysts

  • + Q1 2026 earnings already showed $3.2M service revenue, up from $0.3M a year earlier.[2][3]
  • + Vigoride-9 new commercial contract announced June 17, 2026.[9]
  • + Vigoride 8 is fully booked for 2027, with NASA payloads already cleared through design review.[2][3]
  • + Next Vigoride mission launch is scheduled for September 1, 2026.[1]
  • + Management is guiding to about $10M in 2026 revenue.[2][3]

Risks

  • ! The company still burns cash; one source says operating cash flow was -$23.3 million.[1]
  • ! Momentus has used stock sales to raise money, which can water down existing shareholders.[1]
  • ! This is a tiny company in a competitive space-services market, so one delayed mission can hurt the story.[7]
  • ! The stock has been extremely volatile, so good news can reverse fast.[2][4]

🎯 One thing to take away

If you only remember one thing, it is this: Momentus is no longer just a concept story — it is showing real mission-driven revenue growth in 2026, with new contracts and a fuller launch calendar behind it.[2][3][9] That said, the business is still small, still losing money, and still leaning on outside financing to keep going.[1] So the setup is interesting if you want a high-upside space name with actual contract news, but it is not a calm or clean story. For a retail investor, this is the kind of stock to watch closely for fresh mission wins, launch dates, and any sign that revenue is scaling faster than dilution.

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Want our premium picks too?

Pro subscribers get our strongest pre-pop ideas + real-time buy-zone alerts.

Read more about Premium
📈
Before you buy

Thinking about MNTS?

Our data likes 10 other stocks even more right now — under-the-radar names we believe have monster upside potential. Get the free list before the crowd catches on.

Show me the 10 stocks — free →
Free · no credit card · unsubscribe in one click

Not investment advice. We share research and analyses for educational purposes. Investing in stocks involves risk, including possible loss of capital. Always do your own research.